Celldex Therapeutics Inc. (CLDX)

2.51
NASDAQ : Health Technology
Prev Close 2.50
Day Low/High 2.47 / 2.60
52 Wk Low/High 2.01 / 11.62
Avg Volume 152.80K
Exchange NASDAQ
Shares Outstanding 15.02M
Market Cap 37.55M
EPS -14.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Celldex Therapeutics Initiates METRIC, An Accelerated Approval Study Of Glembatumumab Vedotin In Patients With Triple Negative Breast Cancer

Celldex Therapeutics Initiates METRIC, An Accelerated Approval Study Of Glembatumumab Vedotin In Patients With Triple Negative Breast Cancer

Antibody drug conjugate targets gpNMB, a protein which promotes the migration, invasion and metastasis of breast cancer

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Opportune Selloffs

Opportune Selloffs

This action makes it a good time to add to two quality names.

Today's Perilous Reversal Stock: Celldex Therapeutics (CLDX)

Today's Perilous Reversal Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Setting Up a Pair of Plays

Setting Up a Pair of Plays

Qualcomm seems to be breaking out of a bullish flag, and Celldex has a fantastic chart.

Why I'm Eyeing Airline Stocks

Why I'm Eyeing Airline Stocks

Airline stocks have been helped by a drop in oil prices.

Celldex Therapeutics (CLDX) Marked As A Dead Cat Bounce Stock

Celldex Therapeutics (CLDX) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

6 Charts Explain An Ugly October for Biotech Stocks

6 Charts Explain An Ugly October for Biotech Stocks

For only the second time in 2013, the S&P 500 beat biotech stocks in October.

'Mad Money' Lightning Round: Stick With Rite Aid

'Mad Money' Lightning Round: Stick With Rite Aid

Take profits in Celldex but ADP and Paychex are great stocks, Cramer says.

Jim Cramer's 'Mad Money' Recap: Who's Sorry About Apple Now?

Jim Cramer's 'Mad Money' Recap: Who's Sorry About Apple Now?

Wall Street has a notoriously short memory and the action on Apple proves it, Cramer says.

My Buying List For The Trend Following Portfolio

My Buying List For The Trend Following Portfolio

I'm considering buying Delta, DuPont, GM and others.

First Week Of December 21st Options Trading For Celldex Therapeutics (CLDX)

First Week Of December 21st Options Trading For Celldex Therapeutics (CLDX)

Investors in Celldex Therapeutics, Inc. saw new options begin trading this week, for the December 21st expiration.

Biotech Stock Bubble Debate in 14 Charts

Biotech Stock Bubble Debate in 14 Charts

Biotech stocks have underperformed in the past month. Is this a sign of more selling or just a buying pause?

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Biotech Stock Mailbag: Bubble Debate, Cel-Sci, Zogenix, Zalicus

Biotech Stock Mailbag: Bubble Debate, Cel-Sci, Zogenix, Zalicus

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Analyst's Celldex Call Another Sign Of Biotech Stock Bubble

Analyst's Celldex Call Another Sign Of Biotech Stock Bubble

Predicting $8 billion in sales for a cancer drug with no clinical data is absurd.

Jim Cramer's Top Stock Picks: ACAD CLDX INSY NYX

Jim Cramer's Top Stock Picks: ACAD CLDX INSY NYX

Cramer thinks Acadia Pharmaceuticals, Celldex Therapeutics and Insys Therapeutics are three winning biotechs.

Jim Cramer's 'Mad Money' Recap: 2,000 Shows and Counting

Jim Cramer's 'Mad Money' Recap: 2,000 Shows and Counting

Don't let the current political environment blind you to opportunities, Cramer advises.

Some Weekend Folding Money

Some Weekend Folding Money

I'm content to head into the weekend with my short-term book mostly on the cash side.

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

The 5 Dumbest Things on Wall Street This Week: Sept. 27

The 5 Dumbest Things on Wall Street This Week: Sept. 27

BlackBerry jet-shops, a filmmaker is cast as a crook by the SEC, AIG's CEO Bob Benmosche puts his foot in his mouth and more.

TheStreet Quant Rating: D- (Sell)